Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome

Cell Reports
Caroline Y KuoDonald B Kohn

Abstract

X-linked hyper-immunoglobulin M (hyper-IgM) syndrome (XHIM) is a primary immunodeficiency due to mutations in CD40 ligand that affect immunoglobulin class-switch recombination and somatic hypermutation. The disease is amenable to gene therapy using retroviral vectors, but dysregulated gene expression results in abnormal lymphoproliferation in mouse models, highlighting the need for alternative strategies. Here, we demonstrate the ability of both the transcription activator-like effector nuclease (TALEN) and clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR/Cas9) platforms to efficiently drive integration of a normal copy of the CD40L cDNA delivered by Adeno-Associated Virus. Site-specific insertion of the donor sequence downstream of the endogenous CD40L promoter maintained physiologic expression of CD40L while overriding all reported downstream mutations. High levels of gene modification were achieved in primary human hematopoietic stem cells (HSCs), as well as in cell lines and XHIM-patient-derived T cells. Notably, gene-corrected HSCs engrafted in immunodeficient mice at clinically relevant frequencies. These studies provide the foundation for a permanent curative therapy in XHIM.

Citations

Jan 27, 2019·Expert Review of Clinical Immunology·Tabata T FrançaAntonio Condino-Neto
Mar 7, 2020·Stem Cells Translational Medicine·Karim BenabdellahFrancisco Martin
Oct 10, 2018·Current Opinion in Allergy and Clinical Immunology·Caroline Y Kuo
Sep 17, 2020·Human Gene Therapy·Rajeev RaiAlessia Cavazza
Mar 13, 2019·Nature Reviews. Drug Discovery·Marina CavazzanaEmmanuelle Six
Aug 14, 2019·Immunological Investigations·Liangshan LiShiguo Liu
Feb 7, 2020·F1000Research·Darja KarpovaJohn F DiPersio
Jun 9, 2020·Clinical Genetics·Roya RamezankhaniCatherine M Verfaillie
Feb 11, 2020·Frontiers in Pediatrics·Benedicte Neven, Francesca Ferrua
Jul 12, 2020·Science Immunology·Luigi D NotarangeloHelen C Su
Dec 19, 2020·British Journal of Haematology·Thomas A Fox, Claire Booth
Dec 15, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hanan BloomerAndre Larochelle
Apr 21, 2020·Computational and Structural Biotechnology Journal·A Vipin MenonJin-Wu Nam
May 31, 2019·Emerging Topics in Life Sciences·Marianna RomitoAlessia Cavazza
May 31, 2019·Emerging Topics in Life Sciences·Roland Preece, Christos Georgiadis
Jan 7, 2021·HemaSphere·Benjamin C Houghton, Claire Booth
Feb 5, 2021·Journal of Clinical Medicine·Christi T Salisbury-Ruf, Andre Larochelle
May 31, 2019·Emerging Topics in Life Sciences·Suk See De Ravin, Julie Brault
Oct 29, 2020·Stem Cell Research & Therapy·C EguizabalJ C Izpisua Belmonte
Dec 7, 2020·British Journal of Haematology·Neelam PanchalClaire Booth
Feb 23, 2021·Molecular Therapy. Methods & Clinical Development·Suvd ByambaaYutaka Hanazono
Mar 16, 2021·Frontiers in Immunology·Lisa A Kohn, Donald B Kohn
Mar 29, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ibtissem El Ouar, Abdelhamid Djekoun
Jul 3, 2021·Cells·Lola KonialiMarina Kleanthous
Mar 18, 2020·Genes & Diseases·Zhi-Yong ZhangFang Zhang
Aug 19, 2021·Journal of Immunology and Regenerative Medicine·Antonella Fidanza, Lesley M Forrester
May 29, 2020·Molecular Therapy. Methods & Clinical Development·Celine J RoccaStephanie Cherqui
Sep 9, 2021·Human Gene Therapy·Mario AmendolaEls Verhoeyen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.